Compare KITT & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KITT | COSM |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | United States |
| Employees | 47 | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 13.5M |
| IPO Year | N/A | 2009 |
| Metric | KITT | COSM |
|---|---|---|
| Price | $0.67 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.6M | 528.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $54,426,402.00 |
| Revenue This Year | $2,936.06 | $20.69 |
| Revenue Next Year | N/A | $53.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.97 |
| 52 Week Low | $0.68 | $0.28 |
| 52 Week High | $6.93 | $1.32 |
| Indicator | KITT | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 36.57 |
| Support Level | N/A | $0.35 |
| Resistance Level | $1.06 | $0.50 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 7.85 |
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.